ABII Insider Trading Activity and SEC Form 4 Filings
ABII insider trading summary
No open-market insider purchases or sales of Abraxis BioScience, Inc. (ABII) have been reported on SEC Form 4 in the past 12 months.
Latest ABII insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2010 | Artistry Acquisition Corp. | 10% Owner | Buy | $0 (40,735,300 @ $0.00) |
| Oct 15, 2010 | Celgene Corp | 10% Owner | Buy | $0 (40,735,300 @ $0.00) |
| Nov 10, 2009 | Bruce Wendel | Exec. VP Corporate Development | Sell | $28K (797 @ $35.42) |
| Jun 6, 2008 | David Chen | Director | Sell | $124K (1,875 @ $66.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.